{{short description|American pharmaceutical company}} {{Infobox company | name = Warner Chilcott plc | logo = 220px|Warner Chilcott | industry = Pharmaceutical industry | fate = Acquired by Actavis (now Allergan) | foundation = {{Start date and age|1968}} | founder = Allen McClay | defunct = {{End date and age|2013|10|1}} | location = Rockaway, New Jersey }} '''Warner Chilcott''' (formerly '''Galen''') was a company in the pharmaceutical industry based in Rockaway, New Jersey. It was primarily focused on women's healthcare and dermatology. On October 1, 2013, the company was acquired by Actavis (now Allergan).
==History== ===Predecessor companies=== ====Galen==== In 1968, Sir Allen McClay founded Galen, a sales and marketing organization focused on branded pharmaceutical products in the United Kingdom and the Republic of Ireland.<ref name=history>{{cite news | url=https://www.irishtimes.com/business/warner-chilcott-company-history-1.759409 | title=Warner Chilcott: company history | first=Steven | last=Carroll | newspaper=The Irish Times | date=October 20, 2009}}</ref>
In 1997, the company listed its shares on the London Stock Exchange and the Irish Stock Exchange.<ref name=history/>
====Warner Chilcott==== Warner Chilcott was the generic drug business of Warner–Lambert.
The company Warner-Chilcott published at least one pocket book, ''1000 Calories: Your Diet Program'', in 1966, in Morris Plains, New Jersey.
In 1996, it was sold to Nale Laboratories P.L.C.<ref>{{cite news | url=https://www.nytimes.com/1996/03/02/business/company-news-warner-lambert-to-sell-generic-unit-to-nale.html | title=WARNER-LAMBERT TO SELL GENERIC UNIT TO NALE | agency=Bloomberg Business News | work=The New York Times | date=March 2, 1996}}</ref>
In 2004, the company was acquired by several private equity firms. In 2006, it became a public company via an initial public offering.<ref>{{cite news | url=https://dealbook.nytimes.com/2006/09/21/warner-chilcotts-ipo-prices-below-expected-range/ | title=Warner Chilcott's I.P.O. Prices Below Expected Range | work=The New York Times | date=September 21, 2006}}{{subscription required}}</ref>
===Merger of Galen and Warner Chilcott=== In 2000, Galen acquired Warner Chilcott and listed its American depositary receipts on NASDAQ.<ref name=history/>
In 2004, the company changed its name from Galen to Warner Chilcott.<ref>{{cite news | url=https://www.irishtimes.com/news/galen-to-change-name-to-warner-chilcott-1.979099 | title=Galen to change name to Warner Chilcott | newspaper=The Irish Times | date=May 12, 2004}}</ref>
===Post-merger=== In August 2004, the company prevailed in a patent case by Teva Pharmaceutical Industries related to Sarafem (Fluoxetine).<ref>{{cite news | url=https://www.law360.com/articles/1912/warner-chilcott-prevails-vs-teva-in-sarafem-patent-suit | title=Warner Chilcott Prevails Vs. Teva In Sarafem Patent Suit | first=Marius | last=Meland | work=Law360 | date=August 6, 2004}}</ref> On May 19, 2006, the company received approval from the Food and Drug Administration for Sarafem.<ref>{{cite web | url=https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021860_sarafem_toc.cfm | title=Sarafem (fluoxetine hydrochloride) Tablets | publisher=Food and Drug Administration | date=May 19, 2006}}</ref>
On October 30, 2009, the company acquired the prescription drug business of Procter & Gamble for $3.1 billion.<ref>{{cite press release | url=http://www.evaluategroup.com/Universal/View.aspx?type=Story&id=198742 | title=Warner Chilcott Completes Acquisition of P&G's Global Branded Prescription Pharmaceuticals Business | publisher=Evaluate Group | date=October 30, 2009}}</ref>
On October 1, 2013, the company was acquired by Actavis (now Allergan).<ref>{{cite press release | url=https://www.prnewswire.com/news-releases/actavis-completes-warner-chilcott-acquisition-225944231.html | title=Actavis Completes Warner Chilcott Acquisition | publisher=PR Newswire | date=October 1, 2013}}</ref>
==References== {{Reflist|1}}
Category:1968 establishments in Ireland Category:Pharmaceutical companies established in 1968 Category:Pharmaceutical companies disestablished in 2013 Category:Defunct pharmaceutical companies of the United States Category:Pharmaceutical companies based in New Jersey Category:Defunct companies based in New Jersey Category:2006 initial public offerings Category:2013 mergers and acquisitions Category:Companies formerly listed on the Nasdaq